coronavirus.“As per the lab report states, no infectious virus was detected after 30 seconds of T3X treatment," the pharma company said in a statement.“We believe this will be a breakthrough that will reduce the likelihood of becoming infected with coronavirus through the nose, which is where most cases are contracted," said Dr Brian Huber, CEO and founder of Advanced Penetration Technology, which is based out of Indiana and Texas.“This is a big deal.
It is the type of protection a lot of people have been hoping for and could be a first line of defence against the COVID virus.